TABLE 1.
Clinical characteristics of outpatients and inpatients before and after the implementation of NVBP policy.
| Characteristics | Outpatients | Inpatients | ||||
|---|---|---|---|---|---|---|
| Before (n = 1,265) | After (n = 1,679) | Before (n = 2,065) | After (n = 1,419) | |||
| n (%) | n (%) | p | n (%) | n (%) | p | |
| Male | 659 (52.1) | 880 (52.4) | 0.865 | 1,027 (49.7) | 731 (51.5) | 0.301 |
| Age(y) | 0.876 | 0.423 | ||||
| <60 | 135 (10.7) | 181 (10.8) | 19 (0.9) | 15 (1.6) | ||
| 60∼ | 687 (54.3) | 949 (56.5) | 646 (31.3) | 431 (30.4) | ||
| 70∼ | 213 (16.8) | 285 (17.0) | 713 (34.5) | 463 (32.6) | ||
| ≥80 | 230 (18.2) | 264 (15.7) | 687 (33.3) | 510 (35.9) | ||
| Insurance | 0.593 | 0.005 | ||||
| UEBMI | 693 (54.8) | 902 (53.7) | 1,696 (82.1) | 1,217 (85.8) | ||
| Other insurance | 572 (45.2) | 777 (46.3) | 369 (17.9) | 202 (14.2) | ||
| Comorbidity | ||||||
| MI | 7 (0.6) | 10 (0.6) | 0.881 | 26 (1.3) | 22 (1.6) | 0.469 |
| Apoplexy | 2 (0.2) | 1 (0.1) | 0.407 | 4 (0.2) | 13 (0.9) | 0.003 |
| Dyslipidemia | 101 (8.0) | 136 (8.1) | 0.909 | 83 (4.0) | 86 (6.1) | 0.006 |
| Diabetes mellitus | 394 (31.1) | 519 (30.9) | 0.891 | 793 (38.4) | 567 (40.0) | 0.355 |
| CKD | 121 (9.6) | 149 (8.9) | 0.520 | 210 (10.2) | 92 (6.5) | <0.001 |
| Class of antihypertensive drugs | ||||||
| CCB | 820 (64.9) | 1,019 (60.7) | 0.022 | 1,427 (69.1) | 989 (69.7) | 0.709 |
| ACEI | 130 (10.3) | 161 (9.6) | 0.536 | 386 (18.7) | 252 (17.8) | 0.484 |
| ARB | 490 (38.8) | 581 (34.6) | 0.021 | 720 (34.9) | 466 (32.8) | 0.215 |
| Diuretic | 175 (13.8) | 233 (13.9) | 0.973 | 551 (26.7) | 474 (33.4) | <0.001 |
| β-blocker | 399 (31.5) | 492 (29.3) | 0.191 | 584 (28.3) | 473 (33.3) | 0.001 |
| α-blocker | 23 (1.8) | 29 (1.7) | 0.853 | 122 (5.9) | 129 (9.1) | <0.001 |
| Compound preparation | ||||||
| ARB + Diuretic | 328 (25.9) | 381 (22.7) | 0.042 | 382 (18.5) | 209 (14.7) | 0.004 |
| ARB + CCB | 302 (23.9) | 356 (21.2) | 0.085 | 317 (15.4) | 199 (14.0) | 0.279 |
| ARB + other drug | 13 (1.0) | 27 (1.6) | 0.178 | 19 (0.1) | 28 (2.0) | 0.008 |
| ACEI + Diuretic | 88 (7.0) | 93 (5.6) | 0.113 | 43 (2.1) | 10 (0.7) | 0.001 |
| ACEI + CCB | 63 (5.0) | 120 (7.1) | 0.016 | 24 (1.2) | 50 (3.5) | <0.001 |
| TCM | 731 (57.8) | 933 (55.6) | 0.023 | 1823 (88.3) | 1,216 (85.7) | 0.025 |
Abbreviations: UEBMI, urban employee basic medical insurance; MI, miocardial infarction; CKD, chronic kidney disease; CCB, calcium channel blocker; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.